CLF vs. AVDL
CLF (Cleveland-Cliffs Inc.) and AVDL (Avadel Pharmaceuticals plc) are both stocks. CLF operates in Steel (Basic Materials), while AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare). At a 0.13 correlation, their price movements are largely independent.
Performance
CLF vs. AVDL - Performance Comparison
Loading charts...
Returns By Period
CLF
- 1D
- -6.28%
- 1M
- 15.06%
- YTD
- -4.52%
- 6M
- 2.51%
- 1Y
- 66.84%
- 3Y*
- -7.46%
- 5Y*
- -11.40%
- 10Y*
- 10.01%
AVDL
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CLF vs. AVDL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLF Cleveland-Cliffs Inc. | -4.52% | 41.28% | -53.97% | 26.75% | -26.00% | 49.52% | 77.38% | 12.72% | 6.66% | -14.27% |
AVDL Avadel Pharmaceuticals plc | 0.42% | 105.04% | -25.57% | 97.21% | -11.39% | 20.96% | -11.52% | 192.64% | -68.54% | -21.08% |
Correlation
The correlation between CLF and AVDL is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jun 7, 1996 | 0.13 |
Fundamentals
CLF:
$7.16B
AVDL:
$2.19B
CLF:
-$2.37
AVDL:
-$0.00
CLF:
0.34
AVDL:
8.72
CLF:
1.23
AVDL:
22.31
CLF:
$18.90B
AVDL:
$248.52M
CLF:
-$528.00M
AVDL:
$234.76M
CLF:
$134.00M
AVDL:
$10.13M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLF vs. AVDL — Risk / Return Rank
CLF
AVDL
CLF vs. AVDL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cleveland-Cliffs Inc. (CLF) and Avadel Pharmaceuticals plc (AVDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CLF | AVDL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.21 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.30 | — | — |
| Martin ratioReturn relative to average drawdown | 2.68 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CLF | AVDL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.98 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | — | — |
Drawdowns
CLF vs. AVDL - Drawdown Comparison
Loading charts...
Drawdown Indicators
| CLF | AVDL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.78% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -51.67% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -74.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -82.37% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -82.37% | — | — |
Current DrawdownCurrent decline from peak | -87.07% | — | — |
Average DrawdownAverage peak-to-trough decline | -47.61% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.01% | — | — |
Volatility
CLF vs. AVDL - Volatility Comparison
Loading charts...
Volatility by Period
| CLF | AVDL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.72% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 46.41% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 68.41% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.53% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.05% | — | — |
Dividends
CLF vs. AVDL - Dividend Comparison
Neither CLF nor AVDL has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
AVDL Avadel Pharmaceuticals plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CLF Cleveland-Cliffs Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.82% | 3.10% |
Financials
CLF vs. AVDL - Financials Comparison
This section allows you to compare key financial metrics between Cleveland-Cliffs Inc. and Avadel Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLF and AVDL have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CLF and AVDL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer